tiprankstipranks
Advertisement
Advertisement
Anixa Advances Ovarian Cancer CAR-T With Higher Dosing
PremiumCompany AnnouncementsAnixa Advances Ovarian Cancer CAR-T With Higher Dosing
3M ago
Anixa provides update on Phase 1 ovarian cancer CAR-T clinical trial
Premium
The Fly
Anixa provides update on Phase 1 ovarian cancer CAR-T clinical trial
3M ago
Anixa Biosciences receives USAN Council approval for novel CAR-T therapy name
Premium
The Fly
Anixa Biosciences receives USAN Council approval for novel CAR-T therapy name
4M ago
Anixa Biosciences’ CAR-T therapy granted WHO approval of non-proprietary name
PremiumThe FlyAnixa Biosciences’ CAR-T therapy granted WHO approval of non-proprietary name
6M ago
Anixa Biosciences awarded patent covering breast cancer vaccine technology
Premium
The Fly
Anixa Biosciences awarded patent covering breast cancer vaccine technology
6M ago
Anixa Biosciences executes data transfer with Cleveland Clinic
Premium
The Fly
Anixa Biosciences executes data transfer with Cleveland Clinic
7M ago
Anixa Biosciences files $200M mixed securities shelf
PremiumThe FlyAnixa Biosciences files $200M mixed securities shelf
8M ago
Promising Advancements and Strategic Positioning Propel Anixa Biosciences to a Buy Rating
Premium
Ratings
Promising Advancements and Strategic Positioning Propel Anixa Biosciences to a Buy Rating
8M ago
Anixa completes dosing of fourth cohort in Phase 1 trial of CAR-T/CER-T therapy
Premium
The Fly
Anixa completes dosing of fourth cohort in Phase 1 trial of CAR-T/CER-T therapy
8M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100